Nuveen’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $200M | Sell |
511,927
-271,621
| -35% | -$115M | 0.05% | 278 |
|
|
2026
Q1 | $371M | Sell |
783,548
-355,424
| -31% | -$179M | 0.1% | 160 |
|
|
2025
Q4 | $532M | Sell |
1,138,972
-382,498
| -25% | -$178M | 0.14% | 126 |
|
|
2025
Q3 | $648M | Sell |
1,521,470
-123,415
| -8% | -$47.8M | 0.17% | 104 |
|
|
2025
Q2 | $630M | Sell |
1,644,885
-2,393
| -0.1% | -$862K | 0.17% | 103 |
|
|
2025
Q1 | $569M | Sell |
1,647,278
-218,493
| -12% | -$70.3M | 0.17% | 112 |
|
|
2024
Q4 | $560M | Buy |
1,865,771
+81,105
| +5% | +$28.3M | 0.16% | 112 |
|
|
2024
Q3 | $725M | Sell |
1,784,666
-107,337
| -6% | -$39.3M | 0.2% | 92 |
|
|
2024
Q2 | $608M | Buy |
1,892,003
+335,521
| +22% | +$109M | 0.18% | 107 |
|
|
2024
Q1 | $519M | Sell |
1,556,482
-11,327
| -0.7% | -$3.46M | 0.15% | 124 |
|
|
2023
Q4 | $424M | Sell |
1,567,809
-18,437
| -1% | -$4.56M | 0.14% | 134 |
|
|
2023
Q3 | $390M | Sell |
1,586,246
-5,631
| -0.4% | -$1.54M | 0.14% | 140 |
|
|
2023
Q2 | $483M | Buy |
1,591,877
+42,883
| +3% | +$11.9M | 0.17% | 117 |
|
|
2023
Q1 | $408M | Buy |
1,548,994
+154,409
| +11% | +$39.2M | 0.15% | 130 |
|
|
2022
Q4 | $335M | Sell |
1,394,585
-371,858
| -21% | -$83.3M | 0.13% | 159 |
|
|
2022
Q3 | $325M | Buy |
1,766,443
+73,255
| +4% | +$14.6M | 0.13% | 150 |
|
|
2022
Q2 | $285M | Sell |
1,693,188
-145,893
| -8% | -$31.3M | 0.11% | 172 |
|
|
2022
Q1 | $481M | Buy |
1,839,081
+144,204
| +9% | +$36.2M | 0.16% | 131 |
|
|
2021
Q4 | $435M | Sell |
1,694,877
-138,360
| -8% | -$33.9M | 0.13% | 150 |
|
|
2021
Q3 | $445M | Sell |
1,833,237
-459,244
| -20% | -$112M | 0.14% | 144 |
|
|
2021
Q2 | $474M | Buy |
2,292,481
+195,781
| +9% | +$39.9M | 0.14% | 141 |
|
|
2021
Q1 | $395M | Buy |
2,096,700
+44,691
| +2% | +$7.88M | 0.13% | 151 |
|
|
2020
Q4 | $337M | Sell |
2,052,009
-49,637
| -2% | -$7.26M | 0.11% | 166 |
|
|
2020
Q3 | $262M | Sell |
2,101,646
-25,099
| -1% | -$3.11M | 0.1% | 189 |
|
|
2020
Q2 | $206M | Sell |
2,126,745
-887,452
| -29% | -$92.3M | 0.08% | 220 |
|
|
2020
Q1 | $271M | Buy |
3,014,197
+144,760
| +5% | +$18.7M | 0.13% | 153 |
|
|
2019
Q4 | $424M | Sell |
2,869,437
-54,700
| -2% | -$7.35M | 0.16% | 127 |
|
|
2019
Q3 | $352M | Sell |
2,924,137
-241,044
| -8% | -$31.2M | 0.14% | 143 |
|
|
2019
Q2 | $428M | Buy |
3,165,181
+2,902,715
| +1,106% | +$367M | 0.17% | 120 |
|
|
2019
Q1 | $34.2M | Buy |
262,466
+245,415
| +1,439% | +$33M | 0.18% | 147 |
|
|
2018
Q4 | $2.12M | Buy |
17,051
+208
| +1% | +$27.9K | 0.01% | 613 |
|
|
2018
Q3 | $2.34M | Sell |
16,843
-43
| -0.3% | -$5.35K | 0.01% | 631 |
|
|
2018
Q2 | $1.73M | Buy |
16,886
+534
| +3% | +$54K | 0.01% | 636 |
|
|
2018
Q1 | $1.59M | Sell |
16,352
-1,743
| -10% | -$169K | 0.01% | 651 |
|
|
2017
Q4 | $1.59M | Sell |
18,095
-79
| -0.4% | -$6.35K | 0.01% | 640 |
|
|
2017
Q3 | $1.45M | Sell |
18,174
-13,344
| -42% | -$1.07M | 0.01% | 675 |
|
|
2017
Q2 | $2.75M | Sell |
31,518
-5,911
| -16% | -$500K | 0.02% | 570 |
|
|
2017
Q1 | $3.33M | Sell |
37,429
-77,569
| -67% | -$6.47M | 0.02% | 576 |
|
|
2016
Q4 | $8.51M | Sell |
114,998
-43,232
| -27% | -$3.24M | 0.04% | 496 |
|
|
2016
Q3 | $12M | Buy |
158,230
+97,396
| +160% | +$7.46M | 0.07% | 339 |
|
|
2016
Q2 | $4.68M | Sell |
60,834
-19,261
| -24% | -$1.52M | 0.03% | 513 |
|
|
2016
Q1 | $6.25K | Buy |
80,095
+56,595
| +241% | +$3.95M | 0.03% | 426 |
|
|
2015
Q4 | $1.59K | Buy |
23,500
+3,668
| +18% | +$256K | 0.01% | 866 |
|
|
2015
Q3 | $1.53K | Buy |
19,832
+3,341
| +20% | +$296K | 0.01% | 891 |
|
|
2015
Q2 | $1.5K | Sell |
16,491
-1,433
| -8% | -$115K | 0.01% | 967 |
|
|
2015
Q1 | $1.35M | Buy |
17,924
+11,333
| +172% | +$814K | 0.01% | 1040 |
|
|
2014
Q4 | $484K | Buy |
6,591
+2,415
| +58% | +$170K | ﹤0.01% | 1390 |
|
|
2014
Q3 | $294K | Buy |
+4,176
| New | +$276K | ﹤0.01% | 1448 |
|
|
2014
Q2 | – | Sell |
-23,768
| Closed | -$1.25M | – | 1620 |
|
|
2014
Q1 | $1.25M | Buy |
+23,768
| New | +$1.18M | 0.01% | 1018 |
|
|
2013
Q4 | – | Sell |
-11,509
| Closed | -$492K | – | 1597 |
|
|
2013
Q3 | $492K | Sell |
11,509
-117,306
| -91% | -$4.58M | ﹤0.01% | 1324 |
|
|
2013
Q2 | $4.64M | Buy |
+128,815
| New | +$4.98M | 0.03% | 531 |
|
Other funds holding HCA
Nuveen's HCA Position: Q2 2026 in Review
Nuveen reduced its HCA Healthcare (HCA) stake by 35% in Q2 2026, selling an estimated $115M and leaving 511,927 shares worth $200M. The position accounts for 0.05% of the portfolio, ranked #278.
Nuveen first reported a position in HCA in Q2 2013 and has held it in 51 quarters since. The position peaked at $725M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Nuveen held 511,927 shares of HCA Healthcare worth $200M as of Q2 2026.
- Nuveen sold 271,621 HCA Healthcare shares in Q2 2026, an estimated $115M.
- HCA Healthcare made up 0.05% of Nuveen's portfolio in Q2 2026, its #278 holding.
- Nuveen first reported a position in HCA Healthcare in Q2 2013 and has held it in 51 quarters since.
- Nuveen's HCA Healthcare position peaked at $725M in Q3 2024.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.